OCTAJET Trademark

Trademark Overview

On Wednesday, February 24, 2016, a trademark application was filed for OCTAJET with the United States Patent and Trademark Office. The USPTO has given the OCTAJET trademark a serial number of 79187033. The federal status of this trademark filing is Section 71 & 15 - ACCEPTED AND ACKNOWLEDGED as of Thursday, January 4, 2024. This trademark is owned by Octapharma AG. The OCTAJET trademark is filed in the Medical Instrument Products category with the following description:

Medical apparatus and instruments for reconstituting lyophilized fibrinogen powder; medical devices for transferring water to lyophilized fibrinogen powder to reconstitute the fibrinogen for preparation of fibrinogen solutions for injections and infusions
octajet

General Information

Serial Number79187033
Word MarkOCTAJET
Filing DateWednesday, February 24, 2016
Status739 - Section 71 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateThursday, January 4, 2024
Registration Number5211284
Registration DateTuesday, May 30, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 14, 2017

Trademark Statements

Goods and ServicesMedical apparatus and instruments for reconstituting lyophilized fibrinogen powder; medical devices for transferring water to lyophilized fibrinogen powder to reconstitute the fibrinogen for preparation of fibrinogen solutions for injections and infusions

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, May 27, 2016
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameOctapharma AG
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressLachen CH-8853
CH
Party NameOctapharma AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCH-8853 Lachen
CH
Party NameOctapharma AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCH-8853 Lachen
CH

Trademark Events

Event DateEvent Description
Thursday, June 9, 2016NON-FINAL ACTION WRITTEN
Thursday, May 26, 2016SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, May 27, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 31, 2016APPLICATION FILING RECEIPT MAILED
Thursday, June 9, 2016ASSIGNED TO EXAMINER
Friday, June 10, 2016NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, June 14, 2016REFUSAL PROCESSED BY MPU
Tuesday, June 14, 2016NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, July 2, 2016REFUSAL PROCESSED BY IB
Thursday, August 18, 2016NEW REPRESENTATIVE AT IB RECEIVED
Wednesday, December 14, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 13, 2017ASSIGNED TO LIE
Saturday, January 14, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, January 14, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 23, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, February 4, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, February 22, 2017NOTICE OF PUBLICATION
Wednesday, February 22, 2017NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, February 22, 2017NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Friday, March 10, 2017NOTIFICATION PROCESSED BY IB
Tuesday, March 14, 2017PUBLISHED FOR OPPOSITION
Tuesday, May 30, 2017REGISTERED-PRINCIPAL REGISTER
Wednesday, August 30, 2017FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, September 7, 2017FINAL DISPOSITION PROCESSED
Thursday, September 7, 2017FINAL DISPOSITION NOTICE SENT TO IB
Saturday, October 28, 2017FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, May 8, 2023TEAS SECTION 71 & 15 RECEIVED
Thursday, January 4, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, January 4, 2024REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Thursday, June 6, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, June 6, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, June 6, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, January 4, 2024NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED

Related Keywords

octajet fibrinogen powder medical lyophilized preparation infusions injections solutions reconstitute devices